Pfizer collaborates with BioNTech to develop potential COVID-19 vaccine
The vaccine programme is expected to enter clinical testing by the end of April
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Mar 20
The vaccine programme is expected to enter clinical testing by the end of April
18 Mar 20
The two trials (COUGH 1 and 2) involved nearly 2,000 people with chronic cough due to unknown causes…
We take a look at four innovative healthtech companies in Malaysia, including a cloud-based appointment platform and a…
Moderna has already given a dose of its potential Covid-19 vaccine to a patient
17 Mar 20
Beginning in April, the company expects to deliver approximately 600,000 SARS-CoV-2 tests a month, as it increases production…
17 Mar 20
Baricitinib is already approved to treat moderately to severely active rheumatoid arthritis in adults
German newspaper Die Welt recently reported that President Trump offered to buy the rights to a potential coronavirus…
16 Mar 20
Redx's largest shareholder Moulton Goodies has agreed to sell 74,998,896 shares representing nearly 39.5% of the company to…
16 Mar 20
The study was evaluating Bavencio in addition to CRT in comparison to standard-of-care CRT in patients having untreated…
After the head of the UK treasury pledged £12bn in funding to tackle the coronavirus outbreak, we take…